Editorial: an argument for low ‐dose thiopurine allopurinol combination use as first‐line therapy in inflammatory bowel disease—authors’ reply
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 1, Page 98-99, July 2018.
Source: Alimentary Pharmacology and Therapeutics - Category: Drugs & Pharmacology Authors: A. B. Friedman
,
M. P. Sparrow Source Type: research
More News: Allopurinol | Drugs & Pharmacology